Academic Work
Research, Publications & Awards.
Dr. Michael Ghermezi, MD has contributed to peer-reviewed medical research across multiple disciplines, including pain medicine, cardiovascular medicine, and hematology. His academic work includes published manuscripts, national conference presentations, and educational initiatives focused on improving chronic pain care.
Awards and Recognition
Professional honors and distinctions
Dr. Michael Ghermezi, MD has received professional recognition for excellence in clinical care, medical education, and scholarly achievement. These honors reflect a commitment to advancing pain medicine, physician training, and evidence-based patient care. Learn more about his background on the About Dr. Ghermezi page.
Los Angeles Magazine Top Doctors List
2026
Academic Honors
Distinctions earned throughout training.
Conference Presentations
National and institutional presentations.
Michael Ghermezi, M.D.
Improving Outpatient Chronic Pain Management and Resident Education by Developing Collaborative Educational Resources
Poster presentation · American Society of Regional Anesthesia Pain Medicine Conference, 2024.
Cheng P, et al. Michael Ghermezi, M.D. (contributing author)
Improving Outpatient Chronic Pain Management and Resident Education by Developing Collaborative Educational Resources between Internal Medicine Physicians and Chronic Pain Specialists.
Cedars-Sinai Medical Center Research Symposium, Harvey Morse Auditorium. June 2023.
Award-Winning Presentation – recipient of four honors:
- •Diversity, Equity and Inclusion Ambassador Award, Cedars-Sinai Medical Center (July 2023)
- •Hakimi Award, Cedars-Sinai Medical Center Dept. of Anesthesia (July 2023)
- •Honorable Mention, Annual Sackler Research Symposium (December 2014)
- •Abstract Achievement Award, American Society of Hematology (March 2015)
Peer-Reviewed Publications
A curated bibliography.
Sex Differences in Heart Failure Patients Assessed by Combined Echocardiographic and Cardiopulmonary Exercise Testing. (contributing author)
Frontiers of Cardiovascular Medicine. February 2023.
Combined Echocardiographic and Cardiopulmonary Exercise to assess Determinants of Exercise Limitation in Chronic Obstructive Pulmonary Disease. (contributing author)
Journal of the American Society of Echocardiography. September 2020.
Elotuzumab and Dexamethasone for Relapsed or Refractory Multiple Myeloma Patients: A Retrospective Study. (contributing author)
European Journal of Haematology. March 2018.
Serum B-Cell Maturation Antigen: A Novel Biomarker to both Monitor and Predict Outcomes in Multiple Myeloma Patients.
Haematologica. April 2017.
Impact of Left Ventricular Filling Diameters on Outcome of Patients Undergoing Trans-catheter Aortic Valve Replacement. (3rd author)
European Heart Journal Cardiovascular Imaging. March 2017.
Impact of Right Ventricular Dysfunction and Tricuspid Regurgitation on Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement. (contributing author)
J Am Soc Echocardiogr. January 2017.
Levels of Uninvolved Immunoglobulins Predict Clinical Status and Progression Free Survival for Multiple Myeloma Patients. (3rd author)
British Journal of Haematology. March 2016.
Book Chapters
Contributions to medical textbooks.
Michael Ghermezi, Liu T. Chapter 154: Analgesia and Procedural Sedation. Emergency Medicine Board Review. June 2021.
Michael Ghermezi, Tanen D. Chapter 119: Methemoglobinemia. Pediatric Emergency Medicine Fundamentals. January 2021.
Michael Ghermezi, Tanen D. Chapter 117: Common Pediatric Ingestions. Pediatric Emergency Medicine Fundamentals. January 2021.
Chang C, Michael Ghermezi, Robinson N. Chapter 22: Breech Deliveries. Manual of Obstetric Emergencies. June 2020.
Teaching and Academic Leadership
Educating the next generation of physicians.
Dr. Michael Ghermezi, MD has been actively involved in medical education through resident teaching, conference presentations, and the development of collaborative educational resources in pain medicine and chronic pain management.
Abstracts
Conference and symposium abstracts.
Lack of Significance of ISS Staging and Depth of Response in Predicting Overall Survival of Multiple Myeloma Patients. (contributing author)
Blood 124(21):5771. December 2014.
Levels of Uninvolved Immunoglobulin Predict Clinical Status and Progression-Free Survival for Multiple Myeloma Patients. (contributing author)
Blood 124(21):2125. December 2014.
Circulating BCMA Binding to Its Ligand BAFF Prevents Normal Antibody Production in Multiple Myeloma Patients. (contributing author)
Blood 124(21):4713. December 2014.
Serum B-Cell Maturation Antigen Is a Novel Prognostic Indicator for Multiple Myeloma Patients and Correlates with Clinical Status and Survival.
Blood 124(21):3405. December 2014.
Levels of Uninvolved and Involved Immunoglobulin Predict Clinical Status and Progression Free Survival For Multiple Myeloma Patients. (contributing author)
Hematology Reports (7th International Symposium: Clinical Applications of Free Light Chain and Heavy/Light Chain Analysis) 7(s1) p25. April 2015. ISSN: 2038-8322
Soluble BCMA Binds BAFF Resulting in Immune Deficiency in Multiple Myeloma Patients. (contributing author)
Hematology Reports (7th International Symposium: Clinical Applications of Free Light Chain and Heavy/Light Chain Analysis) 7(s1) p62. April 2015. ISSN: 2038-8322
Circulating BCMA Binding to its Ligand BAFF Prevents Normal Antibody Production in Multiple Myeloma. (contributing author)
Haematologica (20th Congress of the European Hematology Association Meeting) 100:515. June 2015.
Levels of Uninvolved Immunoglobulin Predict Clinical Status and Progression Free Survival for Multiple Myeloma Patients. (contributing author)
Haematologica (20th Congress of the European Hematology Association Meeting) 100:740. June 2015.
Serum B-Cell Maturation Antigen is a Novel Prognostic Indicator for Multiple Myeloma Patients and Correlates with Clinical Status and Survival.
Haematologica (20th Congress of the European Hematology Association Meeting) 100:93-94. June 2015.
Serum B-Cell Maturation Antigen Is A Novel Prognostic Indicator for Multiple Myeloma Patients and Correlates with Clinical Status and Survival. (contributing author)
Clinical Chemistry (American Association for Clinical Chemistry Annual Meeting) pS126 – Abstract A-355. October 2015.
Circulating BCMA Binding to its Ligand BAFF Prevents Normal Antibody Production in Multiple Myeloma Patients. (contributing author)
Clinical Chemistry (American Association for Clinical Chemistry Annual Meeting) pS79 – Abstract A-222. October 2015.
Serum BCMA: A Novel Prognostic Indicator in Patients with Multiple Myeloma.
Cancer Microenvironment (7th International Conference on Tumor Microenvironment: Progression, Therapy and Prevention) 8:46. October 2015.
Improving Outpatient Chronic Pain Management and Resident Education by Developing Collaborative Educational Resources between Internal Medicine Physicians and Chronic Pain Specialists. (contributing author)
Cedars-Sinai Medical Center, Harvey Morse Auditorium. June 2023.
Begin Your Care
Ready to take the next step?
Schedule a consultation with Dr. Michael Ghermezi, MD and begin a personalized plan to reduce pain and restore function.
Book an Appointment